CN Patent

CN107666914A — 帕博西尼的固体剂型

Assigned to Pfizer Inc · Expires 2018-02-06 · 8y expired

What this patent protects

本发明涉及包含水溶性酸的帕博西尼的固体剂型。本文所述的该剂型具有所期望的药代动力学特征。

USPTO Abstract

本发明涉及包含水溶性酸的帕博西尼的固体剂型。本文所述的该剂型具有所期望的药代动力学特征。

Drugs covered by this patent

Patent Metadata

Patent number
CN107666914A
Jurisdiction
CN
Classification
—
Expires
2018-02-06
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.